Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide

Dua polimer hidrofobik, Kollidon® SR dan Eudragit® RSPO serta dua polimer hidrofilik hidroksil propil metilselulosa, iaitu HPMC KIOOLV dan HPMC Kl5M, telah dikaji sebagai bahan pembentukan matriks tablet untuk mengawal pelepasan gliklazida. Two hydrophobic polymers, Kollidon® SR and Eudragit®...

Full description

Bibliographic Details
Main Author: Adebaibi, Mahmoud
Format: Thesis
Language:English
Published: 2008
Subjects:
Online Access:http://eprints.usm.my/29598/1/Development_and_evaluation_of_a_matrix_controlled-release_formulation_of_gliclazide.pdf
_version_ 1825832245151137792
author Adebaibi, Mahmoud
author_facet Adebaibi, Mahmoud
author_sort Adebaibi, Mahmoud
collection USM
description Dua polimer hidrofobik, Kollidon® SR dan Eudragit® RSPO serta dua polimer hidrofilik hidroksil propil metilselulosa, iaitu HPMC KIOOLV dan HPMC Kl5M, telah dikaji sebagai bahan pembentukan matriks tablet untuk mengawal pelepasan gliklazida. Two hydrophobic polymers, Kollidon® SR and Eudragit® RSPO as well as two hydrophilic hydroxypropyl methylcellulose polymers, namely, HPMC KlOOLV and HPMC Kl5M were evaluated as matrix tablet forming materials for sustaining the release of gliclazide.
first_indexed 2024-03-06T14:49:58Z
format Thesis
id usm.eprints-29598
institution Universiti Sains Malaysia
language English
last_indexed 2024-03-06T14:49:58Z
publishDate 2008
record_format dspace
spelling usm.eprints-295982017-03-22T01:59:50Z http://eprints.usm.my/29598/ Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide Adebaibi, Mahmoud RS1-441 Pharmacy and materia medica Dua polimer hidrofobik, Kollidon® SR dan Eudragit® RSPO serta dua polimer hidrofilik hidroksil propil metilselulosa, iaitu HPMC KIOOLV dan HPMC Kl5M, telah dikaji sebagai bahan pembentukan matriks tablet untuk mengawal pelepasan gliklazida. Two hydrophobic polymers, Kollidon® SR and Eudragit® RSPO as well as two hydrophilic hydroxypropyl methylcellulose polymers, namely, HPMC KlOOLV and HPMC Kl5M were evaluated as matrix tablet forming materials for sustaining the release of gliclazide. 2008-07 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/29598/1/Development_and_evaluation_of_a_matrix_controlled-release_formulation_of_gliclazide.pdf Adebaibi, Mahmoud (2008) Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide. Masters thesis, USM.
spellingShingle RS1-441 Pharmacy and materia medica
Adebaibi, Mahmoud
Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide
title Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide
title_full Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide
title_fullStr Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide
title_full_unstemmed Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide
title_short Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide
title_sort development and evaluation of a matrix controlled release formulation of gliclazide
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/29598/1/Development_and_evaluation_of_a_matrix_controlled-release_formulation_of_gliclazide.pdf
work_keys_str_mv AT adebaibimahmoud developmentandevaluationofamatrixcontrolledreleaseformulationofgliclazide